CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials ...
MedPage Today on MSN8d
Trial Data Shed Light on ALS Clinical Research
The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...
News Medical on MSN9h
ALL ALS Consortium creates a central information hub to accelerate ALS research
Consortium announced the launch of its official website, creating a central hub for information about its initiatives and clinical research studies. ALL-ALS.org is designed to inform and engage ...
EurekAlert!1d
ALL ALS consortium launches website to advance ALS research
Consortium announced the launch of its official website, creating a central hub for information about its initiatives and clinical research studies. ALL-ALS.org is designed to inform and engage ...
Cero Therapeutics receives FDA clearance of second IND application for CER-1236
CERo Therapeutics (CERO) announces that the Company has received clearance by the U.S. Food and Drug Administration, FDA, for a second ...
Targeted Oncology5d
Evaluating Key Challenges and Advancements in Prostate Cancer Care
Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and ...
University of California, San Francisco18d
Transforming Pediatric Care: How UCSF Research Is Changing Lives
Thousands of people at UCSF work with the purpose of offering hope for the future of every child. Gabby, HT and Brooklyn are ...